ROCKWELL MEDICAL, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Rockwell Medical, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2017 to Q3 2024.
  • Rockwell Medical, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $321K, a 51.4% increase year-over-year.
  • Rockwell Medical, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $1.13M, a 20.8% increase year-over-year.
  • Rockwell Medical, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $932K, a 196% increase from 2022.
  • Rockwell Medical, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $315K, a 66.6% decline from 2021.
  • Rockwell Medical, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $943K, a 98.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.13M $321K +$109K +51.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.02M $338K +$29K +9.39% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $990K $251K +$58K +30.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $932K $218K -$2K -0.91% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $934K $212K +$36K +20.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $898K $309K +$211K +215% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $687K $193K +$372K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $315K $220K -$165K -42.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $480K $176K -$185K -51.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $665K $98K -$335K -77.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $1M -$179K +$57K +24.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $943K $385K -$366K -48.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.31M $361K +$111K +44.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.2M $433K +$1.89M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$696K -$236K -$1.17M -125% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $475K $751K -$305K -28.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-08
Q3 2020 $780K $250K -$627K -71.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $1.41M -$1.46M -$2.96M -197% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $4.37M $935K -$582K -38.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $4.95M $1.06M -$905K -46.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $5.86M $877K +$262K +42.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $5.59M $1.5M +$136K +9.96% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $5.46M $1.52M +$1.07M +240% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $4.39M $1.96M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-17
Q3 2018 $615K -$1.02M -62.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.37M -$746K -35.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $446K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q3 2017 $1.64M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $2.11M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.